510(k) Report

510(k) · Cleared

Cleared

InVision Precision Cardiac Amyloid

K243866510(k) TraditionalCleared May 21, 2025155-day reviewClass II21 CFR 870.2200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

InVision Medical Technology Corporation · SDJ Adjunctive Cardiac Amyloidosis Status Indicator

Cleared on May 21, 2025 as substantially equivalent to K240860 (Ultromics Limited, 2024) after a 155-day review. Its family tree reaches back 15 generations to 1997.

Decided
May 21, 2025
Review
155 days
Class
Class II
Product code
SDJ
Recalls
None
Predicates
1

Its longest line of descent runs back 15 generations to K962603 (1997). 59 ancestors in all, the oldest K891104 (1989). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2016: 1 other ancestor2015: 2 other ancestors2014: 1 other ancestor2013: 3 other ancestors2010: 2 other ancestors2004: 2 other ancestors2001: 4 other ancestors2009: 1 other ancestor2005: 2 other ancestors2003: 3 other ancestors2000: 5 other ancestors1999: 2 other ancestors1996: 3 other ancestors1995: 1 other ancestor1991: 2 other ancestors2012: 1 other ancestor2006: 1 other ancestor1998: 2 other ancestors1994: 1 other ancestor1992: 2 other ancestors2002: 1 other ancestor1993: 1 other ancestor1989: 1 other ancestorK962603 · Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & Cables · Masimo Corp. · 1997K973887 · Masimo Set MS-1P Pulse Oximeter and the Lnop Series of Sensors and Cables · Masimo Corp. · 1998K982255 · Model 2000 Pulse Oximeter · Ivy Biomedical Systems, Inc. · 1998K991823 · N-395 Pulse Oximeter, Model N-395 · Nellcor Puritan Bennett, Inc. · 1999K012451 · Propaq Encore Models 202, 204, 206; Propaq CS Models 242, 244, 246 · Welch Allyn Protocol, Inc. · 2001K061993 · Equivital, Model EQ-01 · Hidalgo Limited · 2006K081140 · Visensia · Obs Medical · 2008K110953 · Visensia, Visensia with Alert · Obs Medical · 2011K152258 · T3 Software · Etiometry, Inc. · 2016K163065 · T3 Software · Etiometry, Inc. · 2017K190273 · T3 Platform software · Etiometry, Inc. · 2019K202306 · T3 Platform software · Etiometry, Inc. · 2020×2: 2 generations cleared close together, K213230 (2022), K222463 (2022) K240860 · EchoGo Amyloidosis (1.0) · Ultromics Limited · 20241990200020102020
  1. Root · 15 generations backK962603 Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & CablesMasimo Corp. · 1997
  2. 11 generations between
  3. 3 generations backK213230 T3 Platform SoftwareEtiometry, Inc. · 2022
  4. 2 generations backK222463 EchoGo Heart FailureUltromics Limited · 2022
  5. 1 generation backK240860 EchoGo Amyloidosis (1.0)Ultromics Limited · 2024
  6. This deviceK243866 InVision Precision Cardiac AmyloidInVision Medical Technology Corporation · 2025
Show all 15 generations
  1. Root · 15 generations backK962603 Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & CablesMasimo Corp. · 1997
  2. 14 generations backK973887 Masimo Set MS-1P Pulse Oximeter and the Lnop Series of Sensors and…Masimo Corp. · 1998
  3. 13 generations backK982255 Model 2000 Pulse OximeterIvy Biomedical Systems, Inc. · 1998
  4. 12 generations backK991823 N-395 Pulse Oximeter, Model N-395Nellcor Puritan Bennett, Inc. · 1999
  5. 11 generations backK012451 Propaq Encore Models 202, 204, 206; Propaq CS Models 242, 244, 246Welch Allyn Protocol, Inc. · 2001
  6. 10 generations backK061993 Equivital, Model EQ-01Hidalgo Limited · 2006
  7. 9 generations backK081140 VisensiaObs Medical · 2008
  8. 8 generations backK110953 Visensia, Visensia with AlertObs Medical · 2011
  9. 7 generations backK152258 T3 SoftwareEtiometry, Inc. · 2016
  10. 6 generations backK163065 T3 SoftwareEtiometry, Inc. · 2017
  11. 5 generations backK190273 T3 Platform softwareEtiometry, Inc. · 2019
  12. 4 generations backK202306 T3 Platform softwareEtiometry, Inc. · 2020
  13. 3 generations backK213230 T3 Platform SoftwareEtiometry, Inc. · 2022
  14. 2 generations backK222463 EchoGo Heart FailureUltromics Limited · 2022
  15. 1 generation backK240860 EchoGo Amyloidosis (1.0)Ultromics Limited · 2024
  16. This deviceK243866 InVision Precision Cardiac AmyloidInVision Medical Technology Corporation · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−15K962603Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & CablesMasimo Corp.1997—
−14K973887Masimo Set MS-1P Pulse Oximeter and the Lnop Series of Sensors and CablesMasimo Corp.1998—
−13K982255Model 2000 Pulse OximeterIvy Biomedical Systems, Inc.1998—
−12K991823N-395 Pulse Oximeter, Model N-395Nellcor Puritan Bennett, Inc.1999—
−11K012451Propaq Encore Models 202, 204, 206; Propaq CS Models 242, 244, 246Welch Allyn Protocol, Inc.2001—
−10K061993Equivital, Model EQ-01Hidalgo Limited2006—
−9K081140VisensiaObs Medical2008—
−8K110953Visensia, Visensia with AlertObs Medical2011—
−7K152258T3 SoftwareEtiometry, Inc.2016—
−6K163065T3 SoftwareEtiometry, Inc.2017—
−5K190273T3 Platform softwareEtiometry, Inc.2019—
−4K202306T3 Platform softwareEtiometry, Inc.2020—
−3K213230T3 Platform SoftwareEtiometry, Inc.2022—
−2K222463EchoGo Heart FailureUltromics Limited2022—
−1K240860EchoGo Amyloidosis (1.0)Ultromics Limited2024—
0 (this device)K243866InVision Precision Cardiac AmyloidInVision Medical Technology Corporation2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199120
199220
199310
199410
199510
199630
199820
199920
200050
200140
200210
200330
200420
200520
200610
200910
201020
201210
201330
201410
201520
201610
FIG. 1 — Lineage of K243866, 1997–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in SDJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new SDJ device

  1. #1 K240860 EchoGo Amyloidosis (1.0)score 18.2 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K240860EchoGo Amyloidosis (1.0)
Summary page 5
…status indicator. Regulatory class: II Product code: SDJ Predicate Device Proprietary name: Ultromics EchoGo Amyloidosis (K240860) Device Description The InVision Precision Cardiac Amyloid (InVision PCA) is a Software as a Medical Device (SaMD) machine-lear…
Ultromics Limited2024—

Also cleared against K240860: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 9 companies; a new generation was cleared every 1.6 years on median.
  • 7 of the 59 ancestors have a recall of any class.
  • 1 other device also cites its predicate K240860.

How does its category compare?

All SDJ devices

SDJ Adjunctive Cardiac Amyloidosis Status Indicator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · SDJ

2in 2025

2024: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · SDJ

Too few SDJ 510(k)s in any year since 2007 to give a median.

Recalls per year · SDJ

No recall names SDJ since 2007.

Adverse event reports per year · SDJ

No MAUDE report names SDJ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20241—00
20252—00
20260—0—

What is it indicated for?

InVision Precision Cardiac Amyloid is an automated machine learning-based decision support system, indicated as a screening tool for adult patients aged 65 years and over undergoing cardiovascular assessment using echocardiography.

When utilized by an interpreting physician, this device provides information alerting the physician for referral to confirmatory investigations.

InVision Precision Cardiac Amyloid is indicated in adult populations over 65 years of age. Patient management decisions should not be made solely on the results of the InVision Precision Cardiac Amyloid.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K243866: InVision Precision Cardiac Amyloid.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K243866

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026